EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Effectiveness and tolerability of rectal ointment and suppositories containing sucralfate for hemorrhoidal symptoms: a prospective, observational study

Anikó Rita Marik, Ildikó Miklós, Gábor Csukly, Péter Hársfalvi, András Novák

International Journal of Colorectal Disease · 2024

DOI: 10.1007/s00384-024-04642-7 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Colorectal Disease, 2024. Verfasst von Anikó Rita Marik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Egis Pharmaceuticals PLC, Budapest, Hungary. marik.aniko.rita@egis.hu. Hauptthemen laut MEDLINE: Sucralfate, Hemorrhoids, Ointments. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Egis Pharmaceuticals PLC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims A high number of topical products are available for the treatment of hemorrhoidal symptoms. Sucralfate-based topical products constitute a new treatment alternative that act as a mechanical barrier to facilitate healing. The aim of this prospective, observational study was to determine patient- and physician-assessed effectiveness and tolerability of rectal ointment and suppositories containing sucralfate for the treatment of hemorrhoidal symptoms in routine clinical practice.

Methods

Adult patients with diagnosed, mild-to-moderate, symptomatic non-bleeding hemorrhoids treated with rectal ointment or suppositories containing sucralfate were enrolled. Patients were administered treatment twice per day for at least 1 week until symptom resolution and/or for a maximum of 4 weeks. The primary endpoint was patient-assessed effectiveness on a modified Symptom Severity Score (mSSS, range 0 to 14). Physician-assessed effectiveness (9 symptoms, 0 to 5 Likert scale), hemorrhoid grade, and patient satisfaction were also determined.

Results

Five investigators enrolled 60 patients; mean age was 48.4 ± 16.6 years and 72.4% were female. Pain or pressure sensitivity was reported as the most severe symptom by patients, and pressure sensitivity, discharge, soiling, and prolapse by physicians. Mean patient-assessed mSSS at baseline was 6.6 ± 1.9 and was significantly improved overall and in the ointment and suppository groups individually by −4.6 ± 2.0, −4.4 ± 1.8, and −4.8 ± 2.2, respectively ( p < 0.0001). Investigator-assessed mean baseline symptom score was 18.1 ± 3.9 and improved by −7.1 ± 4.5, −6.9 ± 5.4, and −7.3 ± 3.5, respectively ( p < 0.0001). Investigator-assessed symptoms of pressure sensitivity, swelling, and discharge were improved to the greatest extent. Hemorrhoid grade was improved in 38% of patients at the end of treatment. Compliance with treatment was 97.4% and patient satisfaction with application and onset of action was high (81.3% and 76.2%, respectively). Both the ointment and suppository were well tolerated.

Conclusions

The effectiveness of topical ointment or suppository containing sucralfate on patient- and investigator-assessed hemorrhoidal symptoms in real-life clinical practice was demonstrated. Patient satisfaction was high and treatments were well tolerated. Larger controlled trials are warranted to confirm the results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SucralfateHemorrhoidsOintmentsHumansFemaleSuppositoriesMaleMiddle AgedProspective StudiesTreatment OutcomePatient SatisfactionAdultAgedAdministration, Rectal

Stichwörter der Autor:innen

Hemorrhoidal diseaseSucralfate ointmentSucralfate suppositorySymptomsTopical medical device

Substanzen

SucralfateSuppositoriesOintments

Autor:innen und Institutionen

  • Egis Pharmaceuticals PLC, Budapest, Hungary. marik.aniko.rita@egis.hu.
  • Egis Pharmaceuticals PLC, Budapest, Hungary.
  • Bitrial Clinical Research Kft, Budapest, Hungary.
  • Semmelweis University, Budapest, Hungary.

Förderung

  • Egis Pharmaceuticals PLC

Zitieren

APA

Marik, A. R., Miklós, I., Csukly, G., Hársfalvi, P., & Novák, A. (2024). Effectiveness and tolerability of rectal ointment and suppositories containing sucralfate for hemorrhoidal symptoms: a prospective, observational study. International Journal of Colorectal Disease. https://doi.org/10.1007/s00384-024-04642-7

Vancouver

Marik AR, Miklós I, Csukly G, Hársfalvi P, Novák A. Effectiveness and tolerability of rectal ointment and suppositories containing sucralfate for hemorrhoidal symptoms: a prospective, observational study. International Journal of Colorectal Disease. 2024. doi:10.1007/s00384-024-04642-7

BibTeX
@article{Marik2024,
  author = {Marik, Anikó Rita and Miklós, Ildikó and Csukly, Gábor and Hársfalvi, Péter and Novák, András},
  title = {Effectiveness and tolerability of rectal ointment and suppositories containing sucralfate for hemorrhoidal symptoms: a prospective, observational study},
  journal = {International Journal of Colorectal Disease},
  year = {2024},
  doi = {10.1007/s00384-024-04642-7}
}
Kostenlos starten →